✦ LIBER ✦

Use of the day 6 bone marrow to alter remission induction therapy in patients with acute myeloid leukaemia: a leukemia intergroup study

✍ Scribed by G. Browman; H. Preisler; A. Raza; K. Syracuse; N. Azarnia; A. Benger; P. Chervenick; P. D'Arrigo; T. Doeblin; J. Goldberg; A. Gottlieb; H. Grunwald; J. Kirshner; R. Larson; R. Meyer; K. Miller; R. Priore; M. Stein; W. R. Vogler; I. Walker; W. E. C. Wilson; M. Barcos

Book ID: 114711822
Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 390 KB
Volume: 71
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.1989.tb06308.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The selective use of AMSA following high

The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup Study

✍ Richard A. Larson; Roger S. Day; Nozar Azarnia; John M. Bennett; George Browman; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 902 KB

Relationship between the per cent of mar

Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia

✍ H. D. Preisler; N. Azarnia; A. Raza; H. Grunwald; R. Vogler; G. Browman; J. Gold 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

The early reduction of leukemic blasts i

The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; The results of multicenter, prospective Polish adult leukemia group study

✍ Sebastian Grosicki; Jerzy Holowiecki; Sebastian Giebel; Slawomira Kyrcz-Krzemien 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

Adult patients with acute myeloid leukem

Adult patients with acute myeloid leukemia who achieve complete remission after 1 or 2 cycles of induction have a similar prognosis : A report on 1980 patients registered to 6 studies conducted by the Eastern Cooperative Oncology Group

✍ Jacob M. Rowe; Haesook T. Kim; Peter A. Cassileth; Hillard M. Lazarus; Mark R. L 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 360 KB

Autologous bone marrow transplantation a

Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch–Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial

✍ Dimitri A. Breems; Marc A. Boogaerts; Adriaan W. Dekker; Wim L. J. Van Putten; P 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

Adding arabinosylcytosine to idarubicin

Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemia: Abstracted from: Avvisati G, Petti M, Lo-Coco F et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study. LAP 0389 with 7 years of minimal follow-up. Blood 2002; 100 (9): 3141–6.

✍ Elihu Estey; Miguel A. Sanz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 77 KB